Respiratory care software company Somnoware Healthcare Systems Inc. is partnering with sleep technology company Cerebra Medical Ltd. to integrate Cerebra’s autoscoring technology, MY Autoscoring, into the Somnoware platform.
Somnoware is a cloud-based platform for enhanced respiratory care management and hospital-at-home, and the partnership will enable automated sleep study scoring directly within the Somnoware platform.
MY Autoscoring enhances the accuracy, consistency, and efficiency of human scorers, scoring an entire polysomnogram (PSG) in less than five minutes, according to Somnoware. A sleep specialist then reviews and edits the results of the automated scoring and uses the information to diagnose and treat the patient if a sleep disorder is detected.
Named after inventor and Cerebra Scientific founder Magdy Younes, MD, PhD, FRCPC, MY Autoscoring includes Odds Ratio Product (ORP), a Cerebra patented algorithm. ORP goes beyond conventional scoring by micro-analyzing the EEG signal, determining a patient’s sleep depth in each sleep stage. This information is used to better understand a patient’s sleep quality and aid in the diagnosis of sleep disorders such as sleep apnea.
“With MY Autoscoring, clinicians will now be able to automate sleep study scoring within the Somnoware platform,” Somnoware CEO Subath Kamalasan said. “The combined time-savings for clinicians using the integrated platforms is enormous and will reduce costs, decrease testing backlogs, and free up time for patient care.”
“Somnoware is the leading integration innovator in sleep medicine,” said Patrick Crampton, Cerebra President & COO. “With the addition of MY Autoscoring, the sleep medicine community has a platform that not only integrates their testing devices and EHR, but also sleep study autoscoring.”
